Article ; Online: COVID-19 and Candida duobushaemulonii superinfection: A case report.
2021 Volume 31, Issue 3, Page(s) 101168
Abstract: ... to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics ... patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections.: Case description ... broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 ...
| Abstract | Introduction: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections. Case description: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation. He died after recurrent pneumothorax led to respiratory failure and cardiac arrest. Discussion: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients. Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens. Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections. Conclusion: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Adult ; Antifungal Agents/therapeutic use ; COVID-19/complications ; Candida ; Candidemia/complications ; Candidemia/drug therapy ; Fatal Outcome ; Humans ; Male ; Respiration, Artificial ; Respiratory Distress Syndrome ; Saccharomycetales ; Superinfection/complications ; Superinfection/drug therapy | |||||
| Chemical Substances | Antifungal Agents | |||||
| Language | English | |||||
| Publishing date | 2021-06-16 | |||||
| Publishing country | France | |||||
| Document type | Case Reports ; Journal Article | |||||
| ZDB-ID | 1067006-3 | |||||
| ISSN | 1773-0449 ; 1156-5233 | |||||
| ISSN (online) | 1773-0449 | |||||
| ISSN | 1156-5233 | |||||
| DOI | 10.1016/j.mycmed.2021.101168 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3148: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.